Amount Raised
€1.8 Million
Round Type
Seed
Description
STENTiT, a medical device company bringing a novel class of regenerative endovascular implants for the treatment of cardiovascular diseases, has closed a €1.8 million seed investment round. The funding facilitates further pre-clinical development and batch production of a regenerative stent (see video) for peripheral indications. The investment was made by Dutch investors NextGen Ventures, Brabant Development Agency (BOM) and the Ten Cate Investment Company.
Who else raised in Consumer Goods and Health Care around the same time
Companies in the same sectors as Sten Ti T that raised within 45 days of this round, from Fundz verified event records.
- Toothsi raised $40M (Funding Round) on May 2, 2022.
- Upty raised an undisclosed amount (Seed) on April 25, 2022.
- Open Book Extracts raised an undisclosed amount (Series C) on April 6, 2022.
- Open Book Extracts raised $4.2M on April 5, 2022.
- The Valens Company raised an undisclosed amount (Funding Round) on April 5, 2022.
- Legion Health raised $3.7M (Seed) on March 17, 2022.
Who to call at Sten Ti T, and when
A new round usually means Sten Ti T is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Sten Ti T raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Sten Ti T, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Sten Ti T. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Sten Ti T raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Sten Ti T raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.